{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": {
    "pdf_name": "Hsiao_et_al.__2023_"
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 1
  },
  "extracted_evidence": [
    {
      "id": "comp_1",
      "quote": "The Flublok Quadrivalent influenza vaccine (RIV4, Sanofi) is manufactured without chicken eggs, resulting in a recombinant hemagglutinin protein that is genetically identical to that in the selected strain.",
      "relevance_explanation": "This quote supports the claim by stating that Flublok is produced using recombinant technology to express hemagglutinin, and that it is not made using eggs, which is a key feature of the baculovirus expression vector system (BEVS) in insect cells.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ]
}